Richard Scott Blackley - 01 Jun 2024 Form 4 Insider Report for Oscar Health, Inc. (OSCR)

Signature
/s/ Melissa Curtin, Attorney-in-fact
Issuer symbol
OSCR
Transactions as of
01 Jun 2024
Net transactions value
-$479,302
Form type
4
Filing time
04 Jun 2024, 18:05:11 UTC
Previous filing
04 Jun 2024
Next filing
07 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OSCR Class A Common Stock Options Exercise +7,016 +1.1% 621,332 01 Jun 2024 Direct F1
transaction OSCR Class A Common Stock Options Exercise +37,578 +6% 658,910 01 Jun 2024 Direct F1
transaction OSCR Class A Common Stock Options Exercise +8,652 +1.3% 667,562 01 Jun 2024 Direct F1
transaction OSCR Class A Common Stock Sale $467,351 -24,016 -3.6% $19.46 643,546 03 Jun 2024 Direct F2, F3
transaction OSCR Class A Common Stock Sale $11,950 -626 -0.1% $19.09 642,920 04 Jun 2024 Direct F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSCR Restricted Stock Units Options Exercise $0 -7,016 -17% $0.000000 35,079 01 Jun 2024 Class A Common Stock 7,016 Direct F1, F5
transaction OSCR Restricted Stock Units Options Exercise $0 -37,578 -8.3% $0.000000 413,355 01 Jun 2024 Class A Common Stock 37,578 Direct F1, F6
transaction OSCR Restricted Stock Units Options Exercise $0 -8,652 -8.3% $0.000000 95,177 01 Jun 2024 Class A Common Stock 8,652 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.01 to $19.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.01 to $19.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F5 The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021.
F6 The restricted stock units vest in sixteen equal quarterly installments beginning on June 1, 2023.
F7 The restricted stock units vest in twelve equal quarterly installments beginning on June 1, 2024.